Gevo, Inc. (GEVO) Form 8-K — Oct 28, 2026
$GEVOForm 8-KItems 5.02, 7.01, 9.01Filed Oct 28, 2026, 8:12 AM ET0001628280-26-067732Original filing
Gevo announced the appointment of K'Lynne Johnson to its Board of Directors as a Class II director, effective November 4, 2026, with her term expiring at the 2027 annual meeting. She was determined to be an independent director under Nasdaq listing standards. Johnson brings over three decades of executive experience in sustainable technologies, including as founder and former CEO of Elevance Renewable Sciences, a specialty chemicals company using biobased feedstocks. She currently serves on the boards of FMC Corporation, Trinseo PLC, J.M.
Key figures
- Board effective date
- November 4, 2026
- Director cash retainer
- 85000
- Director equity grant value
- 63000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.